Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma (CGH)

OTHER RELATED OMICS DATASETS IN: GSE97293

PROVIDER: PRJNA129867 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma

Project description:Genomic and expression profiling using 38K BAC array-CGH and Illumina HT-12 beadchips were performed on 97 diploid invasive breast tumors to assess the impact of gene dosage on gene expression patterns and the effect of other mechanisms on transcriptional levels. Patient stratification was performed according to axillary lymph node status (node-negative, pN0; node-positive, pN1) and overall survival (>8-year survivors; breast cancer-specific mortality within 8 years of diagnosis). Array-CGH results was validated by FISH using tumors showing HER2/neu gene amplification and expression profiling was confirmed using qPCR for 16 transcripts. This SuperSeries is composed of the following subset Series: GSE20462: Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma (transcriptomic profiling) GSE20483: Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma (CGH) Refer to individual Series

2010-06-10 | E-GEOD-20486 | biostudies-arrayexpress

Homo sapiens

Project description:Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma (transcriptomic profiling)

| PRJNA129555 | ENA

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma

Project description:Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma

| PRJNA125177 | ENA

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma (CGH)

2010-06-10 | GSE20483 | GEO

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma (transcriptomic profiling)

2010-06-10 | GSE20462 | GEO

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma

2010-06-10 | GSE20486 | GEO

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma (CGH)

Project description:Genomic and expression profiling using 38K BAC array-CGH and Illumina HT-12 beadchips were performed on 97 diploid invasive breast tumors to assess the impact of gene dosage on gene expression patterns and the effect of other mechanisms on transcriptional levels. Patient stratification was performed according to axillary lymph node status (node-negative, pN0; node-positive, pN1) and overall survival (>8-year survivors; breast cancer-specific mortality within 8 years of diagnosis). Array-CGH results was validated by FISH using tumors showing HER2/neu gene amplification and expression profiling was confirmed using qPCR for 16 transcripts. Genomic DNA was isolated from fresh-frozen tissue samples

2010-06-10 | E-GEOD-20483 | biostudies-arrayexpress

Homo sapiens

Project description:Breast Tumor Clinical Implications

| PRJNA92851 | ENA

Breast tumors from CHEK2 1100delC mutation carriers: genomic landscape and clinical implications

Project description:This SuperSeries is composed of the following subset Series: GSE24697: Breast tumors from CHEK2 1100delC mutation carriers: genomic landscape and clinical implications (GEX) GSE24698: Breast tumors from CHEK2 1100delC mutation carriers: genomic landscape and clinical implications (CGH) Refer to individual Series

2011-05-10 | E-GEOD-24707 | biostudies-arrayexpress

Homo sapiens

Project description:Breast tumors from CHEK2 1100delC mutation carriers: genomic landscape and clinical implications (CGH)

| PRJNA133635 | ENA